Is Optum Reshaping Healthcare? What It Means for Prices & Referrals

Why It Matters

Optum’s ability to raise ASC prices in markets where it controls both providers and facilities signals a potential anti‑competitive squeeze that could drive higher healthcare costs for insurers and patients alike.

Key Takeaways

• Optum acquires practices already favoring ambulatory surgical centers.
• Referral patterns remain unchanged after Optum’s physician practice purchases.
• Price increases concentrate in markets where Optum controls both ASC and practices.
• Average ASC price rose $239, roughly an 11% increase.
• Vertical integration yields higher facility and physician fees in co‑located markets.

Summary

The Health Affairs paper discussed on the podcast examines UnitedHealth’s Optum unit and its aggressive vertical integration strategy—specifically, the acquisition of physician practices and ambulatory surgical centers (ASCs). By linking insurer, provider, and pharmacy functions, Optum aims to capture more of the care‑delivery value chain, prompting questions about efficiency gains versus anti‑competitive behavior.

The researchers find that Optum does not alter referral behavior after buying a practice; instead, it selectively purchases practices that already send a high share of patients to ASCs—about 81% versus roughly 70% for non‑Optum peers. In terms of pricing, ASC acquisitions raise total procedure costs by an average of $239, an 11% uplift, with the effect magnified in markets where Optum dominates both the ASC and physician‑practice segments.

Dr. Derek Lake highlights that the price hike is split evenly between facility fees and physician fees, but the physician‑fee increase is confined to Optum‑employed doctors in highly co‑located markets, where total price jumps approach $400. The study also notes that these dynamics were observed among traditional Medicare beneficiaries, a group where Optum bears downside risk and thus has strong incentives to manage costs.

The findings suggest that Optum’s integration may generate modest efficiency gains without reshaping referral patterns, yet it leverages market power to lift prices where it holds both provider and facility assets. Policymakers and insurers should monitor such vertical squeezes, as they could erode competition and increase out‑of‑pocket costs for patients.

Original Description

Health Affairs' Rob Lott interviews Derek T. Lake on his recent paper exploring new research on Optum’s acquisitions, finding the company tended to buy physician practices already using ambulatory surgery centers and that its ASC acquisitions were followed by higher prices for competing insurers.

Discover why physician practices already using ASCs are more likely to be acquired by Optum—and how Optum’s ASC purchases are linked to higher prices for competing insurance plans. This conversation explores what these trends mean for healthcare costs, patient access, and the broader market as Optum continues expanding its footprint.

If you're interested in healthcare economics, payer‑provider relationships, market consolidation, or vertical integration, this episode offers data‑driven insights you won’t want to miss.

---

Visit Health Affairs: http://www.healthaffairs.org

Subscribe and Listen to our Podcasts: https://www.healthaffairs.org/podcasts

Sign up for our free Newsletters: https://www.healthaffairs.org/newsletters